Yield on Cost (YOC): 1.21%
The yield on cost (YOC) is 1.21%.
RMD Yield on Cost (YOC) Metrics
YIELD ON COST (YOC)
1.21%
Yield on Cost for RMD
RMD now pays $2.40 per share a year. Measured against the price it actually traded at back then, a long-term holder is earning:
| If you bought | Price then | Yield on cost today |
|---|---|---|
| 10 years ago(2016-06-23) | $64.08 | 3.75% |
| 5 years ago(2021-06-21) | $239.52 | 1.00% |
| 3 years ago(2023-06-22) | $216.52 | 1.11% |
| 1 year ago(2025-06-26) | $256.21 | 0.94% |
| Buying today(at $198.60) | $198.60 | 1.21% |
If you buy today and the dividend keeps growing
Projection: starting from today's 1.21% yield, assuming the dividend keeps compounding at its historical 7.7% rate. Boards set dividends each year, so actual figures will differ.
Today
1.21%
In 3 years
1.69%
In 5 years
2.10%
In 10 years
3.67%
Yield on Cost Calculator
Try your own purchase price, dividend and growth rate for ResMed Inc. (RMD).
Starting Yield
1.21%
Ending YOC
3.68%
Year 15 Dividend
$7.30
Cum. Dividends Recd.
$68.57
| Year | Projected Div. / Share | YoY Dividend Hike | Yield on Cost (YOC) | Total Dividends Recd. |
|---|---|---|---|---|
| Initial | $2.40 | — | 1.21% | $0.00 |
| Year 1 | $2.58 | +7.70% | 1.30% | $2.58 |
| Year 2 | $2.78 | +7.70% | 1.40% | $5.37 |
| Year 3 | $3.00 | +7.70% | 1.51% | $8.37 |
| Year 4 | $3.23 | +7.70% | 1.63% | $11.60 |
| Year 5 | $3.48 | +7.70% | 1.75% | $15.07 |
| Year 6 | $3.75 | +7.70% | 1.89% | $18.82 |
| Year 7 | $4.03 | +7.70% | 2.03% | $22.85 |
| Year 8 | $4.34 | +7.70% | 2.19% | $27.20 |
| Year 9 | $4.68 | +7.70% | 2.36% | $31.88 |
| Year 10 | $5.04 | +7.70% | 2.54% | $36.92 |
| Year 11 | $5.43 | +7.70% | 2.73% | $42.34 |
| Year 12 | $5.85 | +7.70% | 2.94% | $48.19 |
| Year 13 | $6.30 | +7.70% | 3.17% | $54.48 |
| Year 14 | $6.78 | +7.70% | 3.41% | $61.26 |
| Year 15 | $7.30 | +7.70% | 3.68% | $68.57 |
Yield on Cost (YOC) Formula & Definition
Yield on cost is the dividend yield measured against your original purchase price, not today's price. As a company raises its dividend, the yield on what you actually paid keeps rising even when the market yield holds steady.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Yield on Cost (YOC) FAQ
- What is the yield on cost (YOC) for ResMed Inc. (RMD)?
- The yield on cost (YOC) for RMD stock is 1.21%.
About ResMed Inc.
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Michael J. Farrell